Identification of Novel Molecular and Clinical Biomarkers of Survival in Glioblastoma Multiforme Patients: A Study Based on The Cancer Genome Atlas Data

Table 2

Cox regression performed on the top ten signalling pathways determined for the expression data.

Signalling pathway		SE	value	HR	95% CI for HR
					Lower	Upper
Neuroactive ligand-receptor interaction	-0.007	0.025	0.792	0.993	0.946	1.043
Staphylococcus aureus infection	0.000	0.022	0.995	1.000	0.958	1.043
Cytokine-cytokine receptor interaction	-0.013	0.028	0.640	0.987	0.934	1.043
Hematopoietic cell lineage	0.013	0.022	0.558	1.013	0.971	1.057
Complement and coagulation cascades	0.023	0.018	0.206	1.023	0.988	1.060
Viral protein interaction with cytokine and cytokine receptor	0.002	0.018	0.907	1.002	0.967	1.038
Legionellosis	-0.023	0.018	0.208	0.977	0.943	1.013
Amoebiasis	0.014	0.020	0.477	1.015	0.975	1.056
Serotonergic synapse	-0.048	0.026	0.067	0.953	0.905	1.003
cAMP signalling pathway	0.034	0.030	0.257	1.034	0.976	1.096
	0.039	0.010	<0.001	1.040	1.019	1.060